Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:153-160
doi: 10.1161/hq0102.101128
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, A. J.
Right arrow Articles by Jennings, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, A. J.
Right arrow Articles by Jennings, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITROGLYCERIN
Related Collections
Right arrow Animal models of human disease
Right arrow Acute myocardial infarction
Right arrow Other Vascular biology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:153.)
© 2002 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Experimental Rupture of Atherosclerotic Lesions Increases Distal Vascular Resistance

A Limiting Factor to the Success of Infarct Angioplasty

Andrew J. Taylor; Alex Bobik; Michael C. Berndt; Debra Ramsay; Garry Jennings

From the Baker Medical Research Institute and Alfred and Baker Medical Unit, Heart Centre, Alfred Hospital, Melbourne, Australia.

Correspondence to Dr Andrew Taylor, Alfred and Baker Medical Unit, Alfred Hospital and Baker Medical Research Institute, Commercial Road, Prahran, Melbourne 3181, Australia. E-mail a.taylor{at}alfred.org.au

Rupture of atherosclerotic lesions, resulting in localized thrombi and marked falls in distal blood flow, is a pivotal event in unstable coronary syndromes. We tested the hypothesis that after lesion rupture, vasoconstrictor mechanisms are major contributors to a marked rise in distal microvascular resistance, which is responsible for much of the interruption in blood flow. Cholesterol-fed rabbits underwent endothelial denudation of their left iliac arteries to induce angiographically severe, fatty, American Heart Association type IV-like atherosclerotic lesions. After lesion disruption with a stiff wire, we measured distal blood flow and pressure, capillary patency in the distal vascular bed, and the response to the vasodilators adenosine, nitroprusside, and glyceryl trinitrate. Morphology of the lesions and of the associated thrombi was also examined to assess lumen restriction at the site of rupture. Disruption of atherosclerotic lesions reduced mean flow from 5.04±1.21 to 1.23±0.37 mL/min (P<0.005), and calculated distal vascular resistance rose rapidly, from 17.5±2.9 to 37.9±6.4 mm Hg · min/mL (P<0.005). Lesion rupture did not significantly affect capillary patency in the distal muscle vascular bed, and although nonocclusive thrombi were present at the site of nearly all ruptured lesions, embolized thrombi were rare in capillaries (<1%). The early rise in distal microvascular resistance could be normalized with intra-arterially administered adenosine or the NO donor nitroprusside, but not glyceryl trinitrate, an organonitrate possessing large muscular artery-selective vasodilator characteristics. Thus, rupture of atherosclerotic lesions induces rapid and marked increases in distal vascular resistance, which is the consequence of severe microvascular vasoconstriction. Therapeutic targeting of the microvasculature should improve reperfusion in acute coronary syndromes.


Key Words: atherosclerosis • plaque rupture • thrombosis • blood flow • vasodilators




This article has been cited by other articles:


Home page
Eur Heart JHome page
A. Lerman, D. R. Holmes, J. Herrmann, and B. J. Gersh
Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
Eur. Heart J., April 1, 2007; 28(7): 788 - 797.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Herrmann
Peri-procedural myocardial injury: 2005 update
Eur. Heart J., December 1, 2005; 26(23): 2493 - 2519.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Yamashita, E. Furukoji, K. Marutsuka, K. Hatakeyama, H. Yamamoto, S. Tamura, Y. Ikeda, A. Sumiyoshi, and Y. Asada
Increased Vascular Wall Thrombogenicity Combined With Reduced Blood Flow Promotes Occlusive Thrombus Formation in Rabbit Femoral Artery
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2420 - 2424.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. J. Taylor, N. Al-Saadi, H. Abdel-Aty, J. Schulz-Menger, D. R. Messroghli, and M. G. Friedrich
Detection of Acutely Impaired Microvascular Reperfusion After Infarct Angioplasty With Magnetic Resonance Imaging
Circulation, May 4, 2004; 109(17): 2080 - 2085.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Heitzer, I. Ollmann, K. Koke, T. Meinertz, and T. Munzel
Platelet Glycoprotein IIb/IIIa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease
Circulation, August 5, 2003; 108(5): 536 - 541.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Snapir, J. Mikkelsson, M. Perola, A. Penttila, M. Scheinin, and P. J. Karhunen
Variation in the alpha2B-adrenoceptorgene as a risk factor for prehospitalfatal myocardial infarction and sudden cardiac death
J. Am. Coll. Cardiol., January 15, 2003; 41(2): 190 - 194.
[Abstract] [Full Text] [PDF]